Offshore
Photo
Gainify
VOLATILITY LEADERS: Top 10 High-Beta Stocks ($50B+)
$ARM, $MSTR, $COIN, $SHOP, $PLTR, $APP, $HOOD, $RCL, $NVDA, $TSLA
📊 Beta = volatility vs the market → 2.0 means the stock moves 2x more than the S&P 500.
These giants swing at least 2x harder than the market.
Any surprises on this list?
tweet
VOLATILITY LEADERS: Top 10 High-Beta Stocks ($50B+)
$ARM, $MSTR, $COIN, $SHOP, $PLTR, $APP, $HOOD, $RCL, $NVDA, $TSLA
📊 Beta = volatility vs the market → 2.0 means the stock moves 2x more than the S&P 500.
These giants swing at least 2x harder than the market.
Any surprises on this list?
tweet
Offshore
Video
The All-In Podcast
Robinhood CEO Vlad Tenev on tokenizing stocks, expanding access to private company shares, and fintech's future
(0:00) Introducing Vlad Tenev
(0:51) Jason tells his story of investing in Robinhood
(3:17) Tokenizing securities, offering tokenized shares in OpenAI and SpaceX, controversy
(7:29) Operating under Trump vs Biden, why offering tokenized securities for private companies could be revolutionary
(17:01) Criticisms around expanding access to sophisticated financial products
(19:34) Current landscape of financial companies, Robinhood’s future, competing with incumbents
(23:28) Harmonic and building mathematical superintelligence
@vladtenev @RobinhoodApp
tweet
Robinhood CEO Vlad Tenev on tokenizing stocks, expanding access to private company shares, and fintech's future
(0:00) Introducing Vlad Tenev
(0:51) Jason tells his story of investing in Robinhood
(3:17) Tokenizing securities, offering tokenized shares in OpenAI and SpaceX, controversy
(7:29) Operating under Trump vs Biden, why offering tokenized securities for private companies could be revolutionary
(17:01) Criticisms around expanding access to sophisticated financial products
(19:34) Current landscape of financial companies, Robinhood’s future, competing with incumbents
(23:28) Harmonic and building mathematical superintelligence
@vladtenev @RobinhoodApp
tweet
Offshore
Photo
Quiver Quantitative
BREAKING: @elonmusk has bought approximately $1B of Tesla stock.
This is his first purchase on the open market in over 5 years.
$TSLA is up over 5% this morning, and just hit $420. https://t.co/arzN5coVjA
tweet
BREAKING: @elonmusk has bought approximately $1B of Tesla stock.
This is his first purchase on the open market in over 5 years.
$TSLA is up over 5% this morning, and just hit $420. https://t.co/arzN5coVjA
tweet
Offshore
Photo
Gainify
⚠️ VALUATION ALERT: $NVO now trades at just 14.3x P/E (5-yr low). https://t.co/Ef9s2SGcU8
tweet
⚠️ VALUATION ALERT: $NVO now trades at just 14.3x P/E (5-yr low). https://t.co/Ef9s2SGcU8
🚨 GOOD NEWS - $NVO 🚨
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Novo Nordisk announced that the EU has approved an updated label for Rybelsus® (oral semaglutide), making it the first and only oral GLP-1 treatment for type 2 diabetes with proven cardiovascular benefits.
The approval is based on results from the SOUL trial, which showed a 14% reduction in cardiovascular death, heart attack, and stroke compared with placebo.
Additional data also show fewer hospitalisations and consistent benefits across different patient groups. Further findings will be presented at the EASD 2025 meeting. In the US, regulatory decisions are expected later this year on extending Rybelsus®’s cardiovascular indication and on a daily oral Wegovy® pill for obesity with heart disease. Rybelsus®, launched in 2019, is now used by more than 2.4 million people worldwide.
Bullish $NVO! tweet
Offshore
Photo
Quiver Quantitative
JUST IN: Representative Lisa McClain just filed dozens of new stock trades.
She bought stock in UnitedHealth.
This caught my eye because she sits on the House Oversight Subcommittee on Health Care.
$UNH is up 29% since her purchase.
Full trade list up on Quiver. https://t.co/fwcdr1FdeB
tweet
JUST IN: Representative Lisa McClain just filed dozens of new stock trades.
She bought stock in UnitedHealth.
This caught my eye because she sits on the House Oversight Subcommittee on Health Care.
$UNH is up 29% since her purchase.
Full trade list up on Quiver. https://t.co/fwcdr1FdeB
tweet
Yellowbrick Investing
$WIX
tweet
$WIX
We think $WIX remains an asymmetric long even after a ~50% rally driven by bookings acceleration, strong FCF, and buyback yield. The bear case centers on deceleration in the core business, margin compression from Base44, and SBC eating into FCF. we think this is wrong tweet
X (formerly Twitter)
Orel (@orel2589) on X
We think $WIX remains an asymmetric long even after a ~50% rally driven by bookings acceleration, strong FCF, and buyback yield. The bear case centers on deceleration in the core business, margin compression from Base44, and SBC eating into FCF. we think…
Offshore
Photo
Quiver Quantitative
Look at this.
Two months ago, a stock trade by Representative Robert Bresnahan caught our eye.
We posted this report.
$CRDO has now risen 131% since his trade. https://t.co/oOFLIJWwsW
tweet
Look at this.
Two months ago, a stock trade by Representative Robert Bresnahan caught our eye.
We posted this report.
$CRDO has now risen 131% since his trade. https://t.co/oOFLIJWwsW
tweet
Offshore
Photo
Quiver Quantitative
Nancy Pelosi is up $1,600,000 in the stock market so far today.
That is almost 10x her annual salary, in unrealized gains.
Screenshot from Quiver: https://t.co/RFQzXt33B5
tweet
Nancy Pelosi is up $1,600,000 in the stock market so far today.
That is almost 10x her annual salary, in unrealized gains.
Screenshot from Quiver: https://t.co/RFQzXt33B5
tweet
AkhenOsiris
Polymarket just announced markets for EPS earnings season.
This is interesting for a few reasons. Polymarket is taking the BBG consensus as "the number" and the Yes/No question is if the company will beat the number.
Fair to say that stocks tend to move more on guidance than past qtr results. Also, EPS is not even the driving metric for many companies stock moves.
Which leads me to the long understood game in stock markets of beating consensus:
Over the past 10 years, S&P 500 companies have beaten quarterly EPS estimates approximately 74% of the time on average. This figure aligns with other analyses, such as a 74% 10-year average cited in mid-2024. For context, the 5-year average is slightly higher at around 77%, reflecting stronger beat rates in more recent periods. Individual quarters can vary significantly—for instance, Q2 2025 saw a 77% beat rate.
Betting "Yes" is the obvious play here. Since all you are betting on is that EPS number (NOT the stock price reaction).
This would be a lot harder (and potentially more valuable as it would align with buyside ests) if the line moved, as they do on sportsbooks when action is heavily skewed.
tweet
Polymarket just announced markets for EPS earnings season.
This is interesting for a few reasons. Polymarket is taking the BBG consensus as "the number" and the Yes/No question is if the company will beat the number.
Fair to say that stocks tend to move more on guidance than past qtr results. Also, EPS is not even the driving metric for many companies stock moves.
Which leads me to the long understood game in stock markets of beating consensus:
Over the past 10 years, S&P 500 companies have beaten quarterly EPS estimates approximately 74% of the time on average. This figure aligns with other analyses, such as a 74% 10-year average cited in mid-2024. For context, the 5-year average is slightly higher at around 77%, reflecting stronger beat rates in more recent periods. Individual quarters can vary significantly—for instance, Q2 2025 saw a 77% beat rate.
Betting "Yes" is the obvious play here. Since all you are betting on is that EPS number (NOT the stock price reaction).
This would be a lot harder (and potentially more valuable as it would align with buyside ests) if the line moved, as they do on sportsbooks when action is heavily skewed.
tweet